YAKUGAI Ombudsperson "Medwatcher Japan" is the private medical supply supervisory system.
In October 2002, we requested Pfizer Japan Inc. and MHLW to suspend the production of Zithromac (azithromycin hydrate), because tissue half-life is long and symptoms can develop even after the patient is no longer taking the medicine and other medicine can also act as alternatives.
No Related Information
YAKUGAI Ombudsperson "Medwatcher Japan" Tie-up group
160-0022 Tokyo Shinjuku Ward Shinjuku 1-14-4 AM building
TEL : 03（3350）0607 FAX : 03（5363）7080
Mail : info@yakugai.gr.jp
Our members have other regular jobs and volunteer their services free of charge. Our secretariat also serves as part-time basis, and we are currently in the process of facilitating the secretariat function. Therefore, please note that due to limited resources, we might not be able to respond to each inquiry on specific medicine. Thank you for your understanding.
